Passage Bio (PASG) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting called to order at 9:00 A.M. on May 19, 2026, with introductions of board members and key executives.
Virtual format adopted to increase inclusivity and reach more stockholders.
Agenda included formal business matters followed by a Q&A session.
Board and executive committee updates
Introduction of board members and executive team, including the CFO, legal counsel, and independent accountants.
Shareholder proposals
Four proposals presented: election of two Class III directors, ratification of accounting firm, advisory vote on executive compensation, and advisory vote on frequency of future compensation votes.
No advance notice of alternative director nominations received.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Passage Bio
- Q1 2026 net loss narrowed, but cash shortfall drives strategic review and major cost cuts.PASG
Q1 202612 May 2026 - PBFT02 gene therapy demonstrated durable biomarker and clinical benefits in FTD-GRN.PASG
Corporate presentation12 May 2026 - PBFT02 gene therapy shows durable biomarker response and early disease-modifying potential in FTD-GRN.PASG
Corporate presentation20 Apr 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay proposals.PASG
Proxy filing7 Apr 2026 - Shareholders will vote on directors, auditor, and executive pay, with strong governance and ESG focus.PASG
Proxy filing7 Apr 2026 - Gene therapy for FTD-GRN advances with early-stage focus, strong biomarker data, and regulatory planning.PASG
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - PBFT02 delivers durable PGRN elevation in FTD-GRN, with strong safety and pipeline progress.PASG
Corporate presentation3 Mar 2026 - Clinical progress in FTD and Huntington's, improved financials, and cash runway to 1Q 2027.PASG
Q4 20253 Mar 2026 - Gene therapy for FTD-GRN demonstrates strong biomarker response and safety, with key data due in 2024.PASG
Oppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026